抗精神病药物引起的膜分裂和结构重组具有明显的临床特征
Ana Gorse1, Vesela Yordanova2, Jessica Bodosa3
1Univ. Bordeaux, CNRS, Bordeaux INP, CBMN, UMR 5248, F-33600 Pessac, France.
ACS chemical neuroscience
|August 6, 2025
概括
抗精神病药物在脑膜中积累,改变脂质特性,并可能影响多巴胺D2受体 (D2R) 功能. 这项研究揭示了 хлорпромазин 和 clozapine 之间明显的膜重塑作用,为抗精神病作用提供了新的见解.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学 是一个学科.
- 生物物理学的生物物理.
背景情况:
- 抗精神病药物 (AP) 通过与多巴胺D2受体 (D2R) 等大脑点相互作用来治疗严重的精神障碍.
- APs是脂友性,在脂质膜中积累,并充当调节神经递质信号的储库.
- APs可以改变膜的物理化学特性,影响嵌入式蛋白质,如D2R.
研究的目的:
- 为了比较两个主要抗精神病药物 - - хлорпромазин 和 clozapine 的膜重塑特性.
- 研究AP分区如何影响脂质膜特征,超越经典的受体介导机制.
- 了解AP对突触囊泡相关的膜性质的差异影响.
主要方法:
- 利用生物物理方法的组合来研究模仿突触囊泡的脂质模型膜.
- 研究了这些膜内的普罗马зин和克洛扎的分离和积累.
- 评估了AP对膜顺序,相位过渡,厚度,弹性,相位分离,完整性和电荷的影响.
主要成果:
- 克洛普罗马和克洛扎如何分裂并修改脂质膜的明显差异.
- 在两种AP之间观察到对膜物理化学和机械性能的不同影响.
- 突出指出,这些膜修饰可能会根据AP随时间的积累和细胞位置 (前与后突触) 不同.
结论:
- 抗精神病疗效可能与它们独特的膜重塑能力有关,而不仅仅是D2R对抗.
- 与其他AP相比,克洛扎宾的卓越临床疗效可能部分归因于其与其他AP相比明显的膜相互作用.
- 了解AP诱导的膜变化为治疗耐药精神分裂症和AP药物开发提供了新的视角.
更多相关视频
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
12.2K
09:49Brain Membrane Fractionation: An Ex Vivo Approach to Assess Subsynaptic Protein Localization
Published on: May 12, 2017
10.5K
相关概念视频
01:21Antipsychotic Drugs: Typical and Atypical Agents
319
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
319
01:28Psychosis and Antipsychotic Drugs: Overview
456
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
456
01:28Drug Therapy
100
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
100
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
382
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
382
01:26Psychosis: Goals of Pharmacotherapy
209
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
209
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
961
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
961